MARK G FOLETTA Insider Trading $DXCM DEXCOM INC
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for MARK G FOLETTA.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of MARK G FOLETTA. MARK G FOLETTA is Senior VP, Finance & CFO in AMYLIN PHARMACEUTICALS INC ($AMLN) and Sr VP Finance & CFO in AMYLIN PHARMACEUTICALS INC ($AMLN) and SVP Chief Financial Officer in AMYLIN PHARMACEUTICALS INC ($AMLN) and SVP, Chief Financial Officer in AMYLIN PHARMACEUTICALS INC ($AMLN) and VP & Chief Financial Officer in AMYLIN PHARMACEUTICALS INC ($AMLN) and VP Finance & CFO in AMYLIN PHARMACEUTICALS INC ($AMLN) and Director in AMN HEALTHCARE SERVICES INC ($AHS) and Director in DEXCOM INC ($DXCM) and Director in ENANTA PHARMACEUTICALS INC ($ENTA) and Interim CFO in BIOCEPT INC ($BIOC) and EVP & Chief Financial Officer in Tocagen Inc ($TOCA) and Director in Regulus Therapeutics Inc. ($RGLS).
MARK G FOLETTA in DEXCOM INC
Industry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
Position of MARK G FOLETTA: Director
Holdings: 15,160 shares
Current Value: $1,207,797
Latest Transaction: Oct 19 2020
$DXCM Market Capitalization: $6.75B
$DXCM Previous Close: $79.67
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of MARK G FOLETTA in DEXCOM INC
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AHS, AMLN, BIOC, DXCM, ENTA, TOCA, RGLS
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 19 2020 | DXCM | DEXCOM INC | FOLETTA MARK G | Director | Sell | S | 398.25 | 208 | 82,835 | 14,202 | 14.4 K to 14.2 K (-1.44 %) |
| Oct 19 2020 | DXCM | DEXCOM INC | FOLETTA MARK G | Director | Sell | S | 397.41 | 375 | 149,030 | 14,410 | 14.8 K to 14.4 K (-2.54 %) |
| Oct 19 2020 | DXCM | DEXCOM INC | FOLETTA MARK G | Director | Sell | S | 396.51 | 255 | 101,109 | 14,785 | 15 K to 14.8 K (-1.70 %) |
| Oct 19 2020 | DXCM | DEXCOM INC | FOLETTA MARK G | Director | Sell | S | 395.02 | 120 | 47,402 | 15,040 | 15.2 K to 15 K (-0.79 %) |
| Oct 19 2020 | DXCM | DEXCOM INC | FOLETTA MARK G | Director | Sell | S | 391.48 | 42 | 16,442 | 15,160 | 15.2 K to 15.2 K (-0.28 %) |
| Sep 16 2020 | DXCM | DEXCOM INC | FOLETTA MARK G | Director | Sell | S | 397.75 | 114 | 45,344 | 15,202 | 15.3 K to 15.2 K (-0.74 %) |
| Sep 16 2020 | DXCM | DEXCOM INC | FOLETTA MARK G | Director | Sell | S | 397.75 | 114 | 45,344 | 15,202 | 15.3 K to 15.2 K (-0.74 %) |
| Sep 16 2020 | DXCM | DEXCOM INC | FOLETTA MARK G | Director | Sell | S | 396.17 | 121 | 47,936 | 15,316 | 15.4 K to 15.3 K (-0.78 %) |
| Sep 16 2020 | DXCM | DEXCOM INC | FOLETTA MARK G | Director | Sell | S | 396.17 | 121 | 47,936 | 15,316 | 15.4 K to 15.3 K (-0.78 %) |
| Sep 16 2020 | DXCM | DEXCOM INC | FOLETTA MARK G | Director | Sell | S | 395.28 | 222 | 87,753 | 15,437 | 15.7 K to 15.4 K (-1.42 %) |
| Sep 16 2020 | DXCM | DEXCOM INC | FOLETTA MARK G | Director | Sell | S | 395.28 | 222 | 87,753 | 15,437 | 15.7 K to 15.4 K (-1.42 %) |
| Sep 16 2020 | DXCM | DEXCOM INC | FOLETTA MARK G | Director | Sell | S | 393.73 | 231 | 90,951 | 15,659 | 15.9 K to 15.7 K (-1.45 %) |
| Sep 16 2020 | DXCM | DEXCOM INC | FOLETTA MARK G | Director | Sell | S | 393.73 | 231 | 90,951 | 15,659 | 15.9 K to 15.7 K (-1.45 %) |
| Sep 16 2020 | DXCM | DEXCOM INC | FOLETTA MARK G | Director | Sell | S | 391.95 | 200 | 78,390 | 15,890 | 16.1 K to 15.9 K (-1.24 %) |
| Sep 16 2020 | DXCM | DEXCOM INC | FOLETTA MARK G | Director | Sell | S | 391.95 | 200 | 78,390 | 15,890 | 16.1 K to 15.9 K (-1.24 %) |
| Sep 16 2020 | DXCM | DEXCOM INC | FOLETTA MARK G | Director | Sell | S | 390.86 | 109 | 42,604 | 16,090 | 16.2 K to 16.1 K (-0.67 %) |
| Sep 16 2020 | DXCM | DEXCOM INC | FOLETTA MARK G | Director | Sell | S | 390.86 | 109 | 42,604 | 16,090 | 16.2 K to 16.1 K (-0.67 %) |
| Sep 16 2020 | DXCM | DEXCOM INC | FOLETTA MARK G | Director | Sell | S | 386.21 | 3 | 1,159 | 16,199 | 16.2 K to 16.2 K (-0.02 %) |
| Sep 16 2020 | DXCM | DEXCOM INC | FOLETTA MARK G | Director | Sell | S | 386.21 | 3 | 1,159 | 16,199 | 16.2 K to 16.2 K (-0.02 %) |
| May 27 2020 | DXCM | DEXCOM INC | FOLETTA MARK G | Director | Buy | J | 0.00 | 3,055 | 0 | 16,202 | 13.1 K to 16.2 K (+23.24 %) |
| May 27 2020 | DXCM | DEXCOM INC | FOLETTA MARK G | Director | Grant | A | 0.00 | 895 | 1 | 895 | 0 to 895 |
| May 27 2020 | DXCM | DEXCOM INC | FOLETTA MARK G | Director | Sell | J | 0.00 | 3,055 | 0 | 0 | 3.1 K to 0 (-100.00 %) |
| Mar 04 2020 | DXCM | DEXCOM INC | FOLETTA MARK G | Director | Sell | S | 288.26 | 84 | 24,214 | 13,147 | 13.2 K to 13.1 K (-0.63 %) |
| Mar 04 2020 | DXCM | DEXCOM INC | FOLETTA MARK G | Director | Sell | S | 285.48 | 75 | 21,411 | 13,231 | 13.3 K to 13.2 K (-0.56 %) |
| Mar 04 2020 | DXCM | DEXCOM INC | FOLETTA MARK G | Director | Sell | S | 282.77 | 84 | 23,753 | 13,306 | 13.4 K to 13.3 K (-0.63 %) |
| Mar 04 2020 | DXCM | DEXCOM INC | FOLETTA MARK G | Director | Sell | S | 281.61 | 53 | 14,925 | 13,390 | 13.4 K to 13.4 K (-0.39 %) |
| Mar 04 2020 | DXCM | DEXCOM INC | FOLETTA MARK G | Director | Sell | S | 279.60 | 31 | 8,668 | 13,443 | 13.5 K to 13.4 K (-0.23 %) |
| Mar 04 2020 | DXCM | DEXCOM INC | FOLETTA MARK G | Director | Sell | S | 277.48 | 64 | 17,759 | 13,474 | 13.5 K to 13.5 K (-0.47 %) |
| Mar 04 2020 | DXCM | DEXCOM INC | FOLETTA MARK G | Director | Sell | S | 275.56 | 114 | 31,414 | 13,538 | 13.7 K to 13.5 K (-0.84 %) |
| Mar 04 2020 | DXCM | DEXCOM INC | FOLETTA MARK G | Director | Sell | S | 274.88 | 155 | 42,607 | 13,652 | 13.8 K to 13.7 K (-1.12 %) |
| Mar 04 2020 | DXCM | DEXCOM INC | FOLETTA MARK G | Director | Sell | S | 272.82 | 81 | 22,098 | 13,807 | 13.9 K to 13.8 K (-0.58 %) |
| Mar 04 2020 | DXCM | DEXCOM INC | FOLETTA MARK G | Director | Sell | S | 271.54 | 152 | 41,274 | 13,888 | 14 K to 13.9 K (-1.08 %) |
| Mar 04 2020 | DXCM | DEXCOM INC | FOLETTA MARK G | Director | Sell | S | 270.63 | 107 | 28,957 | 14,040 | 14.1 K to 14 K (-0.76 %) |
| Feb 05 2020 | DXCM | DEXCOM INC | FOLETTA MARK G | Director | Sell | S | 240.68 | 9 | 2,166 | 14,147 | 14.2 K to 14.1 K (-0.06 %) |
| Feb 05 2020 | DXCM | DEXCOM INC | FOLETTA MARK G | Director | Sell | S | 238.86 | 166 | 39,650 | 14,156 | 14.3 K to 14.2 K (-1.16 %) |
| Feb 05 2020 | DXCM | DEXCOM INC | FOLETTA MARK G | Director | Sell | S | 238.05 | 524 | 124,736 | 14,322 | 14.8 K to 14.3 K (-3.53 %) |
| Feb 05 2020 | DXCM | DEXCOM INC | FOLETTA MARK G | Director | Sell | S | 236.85 | 301 | 71,290 | 14,846 | 15.1 K to 14.8 K (-1.99 %) |
| Jan 07 2020 | DXCM | DEXCOM INC | FOLETTA MARK G | Director | Sell | S | 218.94 | 133 | 29,118 | 15,147 | 15.3 K to 15.1 K (-0.87 %) |
| Jan 07 2020 | DXCM | DEXCOM INC | FOLETTA MARK G | Director | Sell | S | 218.39 | 339 | 74,035 | 15,280 | 15.6 K to 15.3 K (-2.17 %) |
| Jan 07 2020 | DXCM | DEXCOM INC | FOLETTA MARK G | Director | Sell | S | 217.61 | 528 | 114,899 | 15,619 | 16.1 K to 15.6 K (-3.27 %) |
| Jan 07 2020 | DXCM | DEXCOM INC | FOLETTA MARK G | Director | Sell | S | 218.94 | 133 | 29,118 | 15,147 | 15.3 K to 15.1 K (-0.87 %) |
| Jan 07 2020 | DXCM | DEXCOM INC | FOLETTA MARK G | Director | Sell | S | 218.39 | 339 | 74,035 | 15,280 | 15.6 K to 15.3 K (-2.17 %) |
| Jan 07 2020 | DXCM | DEXCOM INC | FOLETTA MARK G | Director | Sell | S | 217.61 | 528 | 114,899 | 15,619 | 16.1 K to 15.6 K (-3.27 %) |
| Dec 05 2019 | DXCM | DEXCOM INC | FOLETTA MARK G | Director | Sell | S | 228.93 | 462 | 105,766 | 16,147 | 16.6 K to 16.1 K (-2.78 %) |
| Dec 05 2019 | DXCM | DEXCOM INC | FOLETTA MARK G | Director | Sell | S | 227.66 | 233 | 53,046 | 16,609 | 16.8 K to 16.6 K (-1.38 %) |
| Dec 05 2019 | DXCM | DEXCOM INC | FOLETTA MARK G | Director | Sell | S | 226.20 | 232 | 52,478 | 16,842 | 17.1 K to 16.8 K (-1.36 %) |
| Dec 05 2019 | DXCM | DEXCOM INC | FOLETTA MARK G | Director | Sell | S | 223.41 | 70 | 15,639 | 17,074 | 17.1 K to 17.1 K (-0.41 %) |
| Dec 05 2019 | DXCM | DEXCOM INC | FOLETTA MARK G | Director | Sell | S | 221.34 | 3 | 664 | 17,144 | 17.1 K to 17.1 K (-0.02 %) |
| Jun 04 2019 | DXCM | DEXCOM INC | FOLETTA MARK G | Director | Grant | A | 0.00 | 3,055 | 3 | 3,055 | 0 to 3.1 K |
| Jun 04 2019 | DXCM | DEXCOM INC | FOLETTA MARK G | Director | Buy | J | 0.00 | 4,052 | 0 | 17,147 | 13.1 K to 17.1 K (+30.94 %) |
| Jun 04 2019 | DXCM | DEXCOM INC | FOLETTA MARK G | Director | Sell | J | 0.00 | 4,052 | 0 | 0 | 4.1 K to 0 (-100.00 %) |
| May 17 2019 | DXCM | DEXCOM INC | FOLETTA MARK G | Director | Sell | S | 122.73 | 400 | 49,091 | 13,095 | 13.5 K to 13.1 K (-2.96 %) |
| May 17 2019 | DXCM | DEXCOM INC | FOLETTA MARK G | Director | Sell | S | 121.88 | 500 | 60,939 | 13,495 | 14 K to 13.5 K (-3.57 %) |
| May 17 2019 | DXCM | DEXCOM INC | FOLETTA MARK G | Director | Sell | S | 118.65 | 100 | 11,865 | 13,995 | 14.1 K to 14 K (-0.71 %) |
| Apr 17 2019 | DXCM | DEXCOM INC | FOLETTA MARK G | Director | Sell | S | 119.36 | 599 | 71,497 | 14,095 | 14.7 K to 14.1 K (-4.08 %) |
| Apr 17 2019 | DXCM | DEXCOM INC | FOLETTA MARK G | Director | Sell | S | 118.88 | 301 | 35,784 | 14,694 | 15 K to 14.7 K (-2.01 %) |
| Apr 17 2019 | DXCM | DEXCOM INC | FOLETTA MARK G | Director | Sell | S | 116.96 | 100 | 11,696 | 14,995 | 15.1 K to 15 K (-0.66 %) |
| Mar 19 2019 | DXCM | DEXCOM INC | FOLETTA MARK G | Director | Sell | S | 151.97 | 100 | 15,197 | 15,095 | 15.2 K to 15.1 K (-0.66 %) |
| Mar 19 2019 | DXCM | DEXCOM INC | FOLETTA MARK G | Director | Sell | S | 151.00 | 700 | 105,698 | 15,195 | 15.9 K to 15.2 K (-4.40 %) |
| Mar 19 2019 | DXCM | DEXCOM INC | FOLETTA MARK G | Director | Sell | S | 146.92 | 200 | 29,384 | 15,895 | 16.1 K to 15.9 K (-1.24 %) |
| Feb 20 2019 | DXCM | DEXCOM INC | FOLETTA MARK G | Director | Sell | S | 149.52 | 200 | 29,904 | 16,095 | 16.3 K to 16.1 K (-1.23 %) |
| Feb 20 2019 | DXCM | DEXCOM INC | FOLETTA MARK G | Director | Sell | S | 148.52 | 800 | 118,819 | 16,295 | 17.1 K to 16.3 K (-4.68 %) |
| Aug 28 2018 | DXCM | DEXCOM INC | FOLETTA MARK G | Director | Sell | S | 137.50 | 1,000 | 137,503 | 17,095 | 18.1 K to 17.1 K (-5.53 %) |
| Jun 04 2018 | DXCM | DEXCOM INC | FOLETTA MARK G | Director | Grant | A | 0.00 | 4,062 | 4 | 9,014 | 5 K to 9 K (+82.03 %) |
| Nov 29 2017 | DXCM | DEXCOM INC | FOLETTA MARK G | Director | Sell | S | 54.95 | 2,500 | 137,386 | 13,143 | 15.6 K to 13.1 K (-15.98 %) |
| Jun 05 2017 | DXCM | DEXCOM INC | FOLETTA MARK G | Director | Grant | A | 0.00 | 4,952 | 5 | 20,595 | 15.6 K to 20.6 K (+31.66 %) |
| Sep 09 2016 | DXCM | DEXCOM INC | FOLETTA MARK G | Director | Sell | S | 94.63 | 1,800 | 170,325 | 15,643 | 17.4 K to 15.6 K (-10.32 %) |
| May 26 2016 | DXCM | DEXCOM INC | FOLETTA MARK G | Director | Grant | A | 0.00 | 5,450 | 5 | 17,443 | 12 K to 17.4 K (+45.44 %) |
| Jun 05 2015 | DXCM | DEXCOM INC | FOLETTA MARK G | Director | Grant | A | 0.00 | 4,671 | 5 | 11,993 | 7.3 K to 12 K (+63.79 %) |
Page: 1